Published in Virchows Arch on November 30, 2014
ZFP521 contributes to pre-B-cell lymphomagenesis through modulation of the pre-B-cell receptor signaling pathway. Oncogene (2015) 0.82
New developments in the pathology of malignant lymphoma: a review of the literature published from October 2014-December 2014. J Hematop (2015) 0.75
Pembrolizumab in classical Hodgkin's lymphoma. Eur J Haematol (2016) 0.75
Expression of Bruton's tyrosine kinase in B-cell neoplasms evaluated by flow cytometry. Clin Exp Med (2016) 0.75
Emerging treatment options for the management of Hodgkin's lymphoma: clinical utility of nivolumab. J Blood Med (2017) 0.75
The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature (1993) 7.39
A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. J Exp Med (1996) 2.70
Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL). Blood (2013) 2.03
Bruton's tyrosine kinase is essential for human B cell tolerance. J Exp Med (2004) 1.94
Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol (1994) 1.81
Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A (1997) 1.79
Bruton tyrosine kinase (BTK) and its role in B-cell malignancy. Int Rev Immunol (2012) 1.61
The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species. Bioessays (2001) 1.52
BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB. Cell Signal (2012) 1.51
Role of Bruton's tyrosine kinase in immunodeficiency. Curr Opin Immunol (1994) 1.37
The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur J Immunol (1993) 1.21
Expression of Bruton's tyrosine kinase protein within the B cell lineage. Eur J Immunol (1994) 1.20
Btk regulates B cell receptor-mediated antigen processing and presentation by controlling actin cytoskeleton dynamics in B cells. J Immunol (2009) 1.20
Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells. Semin Immunol (2005) 1.12
Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas. J Pathol (2006) 1.04
Inhibitors of BTK and ITK: state of the new drugs for cancer, autoimmunity and inflammatory diseases. Scand J Immunol (2013) 1.02
Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood (2003) 1.01
Bruton's tyrosine kinase (BTK) inhibitors in clinical trials. Curr Hematol Malig Rep (2014) 1.01
Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. Blood (2012) 1.01
Bruton's tyrosine kinase (Btk)-the critical tyrosine kinase in LPS signalling? Immunol Lett (2004) 0.98
Bruton's Tyrosine Kinase is involved in innate and adaptive immunity. Histol Histopathol (2005) 0.91
Discovery of a potent, covalent BTK inhibitor for B-cell lymphoma. ACS Chem Biol (2014) 0.88
Tyrosine kinase Btk is required for NK cell activation. J Biol Chem (2012) 0.87
The role of the tec kinase Bruton's tyrosine kinase (Btk) in leukocyte recruitment. Int Rev Immunol (2012) 0.82
Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype. Clin Exp Immunol (2000) 0.79
Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells. Eur J Immunol (2010) 0.78
A BstNI polymorphism at the BTK locus in Xq21.3-Xq22. Hum Mol Genet (1993) 0.76
MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer (2007) 2.94
Apolipoprotein epsilon4 allele is associated with psoriasis severity. Arch Dermatol Res (2010) 2.66
Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood (2005) 1.99
Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. J Am Soc Nephrol (2010) 1.72
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood (2009) 1.64
The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas. Haematologica (2006) 1.60
Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. Histopathology (2012) 1.52
Topical tacrolimus: an effective therapy for Zoon balanitis. Arch Dermatol (2004) 1.40
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol (2003) 1.27
Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica (2007) 1.25
PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma. Haematologica (2006) 1.23
Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome. Blood (2010) 1.17
Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol (2009) 1.09
APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status. Blood (2010) 1.09
Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas. J Pathol (2013) 1.09
Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies. Br J Haematol (2007) 1.07
Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets. Blood (2012) 1.07
B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. J Clin Invest (2007) 1.05
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features. Haematologica (2013) 0.96
BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations. Br J Haematol (2008) 0.96
Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%. Br J Haematol (2010) 0.95
Transmembrane adaptor molecules: a new category of lymphoid-cell markers. Blood (2005) 0.93
Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer. BMC Cancer (2013) 0.93
ZAP-70 expression in normal pro/pre B cells, mature B cells, and in B-cell acute lymphoblastic leukemia. Clin Cancer Res (2006) 0.92
Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers. Histopathology (2013) 0.92
Cancer-associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling. Int J Cancer (2006) 0.92
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood (2006) 0.92
Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells? Diagn Mol Pathol (2002) 0.91
Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS. Blood (2011) 0.90
Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics. Am J Surg Pathol (2012) 0.89
Purification and characterization of a monooxygenase involved in the biosynthetic pathway of the antitumor drug mithramycin. J Bacteriol (2003) 0.89
Mutation analysis of the LCE3B/LCE3C genes in Psoriasis. BMC Med Genet (2010) 0.89
Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis. Am J Pathol (2010) 0.88
Automated brightfield break-apart in situ hybridization (ba-ISH) application: ALK and MALT1 genes as models. Methods (2010) 0.87
Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent manner. J Immunol (2014) 0.85
Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples. Br J Haematol (2004) 0.84
Detection of genetic alterations by immunoFISH analysis of whole cells extracted from routine biopsy material. J Mol Diagn (2007) 0.84
Peripheral T-cell lymphoma with a follicular growth pattern: derivation from follicular helper T cells and relationship to angioimmunoblastic T-cell lymphoma. Br J Haematol (2008) 0.84
Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays? Histopathology (2011) 0.83
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes. Br J Haematol (2009) 0.83
Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia? Haematologica (2009) 0.82
Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma. Am J Pathol (2010) 0.82
Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues. Pathol Res Pract (2009) 0.82
Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia. Am J Clin Pathol (2009) 0.82
Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells. Br J Haematol (2004) 0.81
Pyoderma gangrenosum after thoracic surgery. Ann Thorac Surg (2011) 0.81
Psoriasis induced by cetuximab: a paradoxical adverse effect. Australas J Dermatol (2010) 0.81
Influence of endothelial nitric oxide synthase polymorphisms in psoriasis risk. Arch Dermatol Res (2011) 0.80
Resequencing of the IL12B gene in psoriasis patients with the rs6887695/rs3212227 risk genotypes. Cytokine (2012) 0.80
BRAF V600E mutation-specific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia. Br J Haematol (2013) 0.80
Labeling of multiple cell markers and mRNA using automated apparatus. Appl Immunohistochem Mol Morphol (2008) 0.80
Guttate psoriasis induced by infliximab in a child with Crohn's disease. Inflamm Bowel Dis (2008) 0.80
ALDH, CA I, and CD2AP: novel, diagnostically useful immunohistochemical markers to identify erythroid precursors in bone marrow biopsy specimens. Am J Clin Pathol (2012) 0.79
Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis. Cytokine (2010) 0.79
Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive. Histopathology (2011) 0.79
Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas. Diagn Pathol (2014) 0.79
Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets. Am J Surg Pathol (2014) 0.79
The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma. J Mol Histol (2005) 0.79
Psoriasis and type 2 diabetes risk among psoriatic patients in a Spanish population. Australas J Dermatol (2011) 0.78
The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients. Arch Dermatol Res (2014) 0.78
Follicular lymphoma with trisomy 18 exhibiting loss of BCL-2 expression on transformation to a large cell lymphoma. J Clin Pathol (2006) 0.78
Histopathology of B-cell chronic lymphocytic leukemia. Hematol Oncol Clin North Am (2004) 0.78
Single hippocratic (clubbed) finger revealing an underlying enchondroma. J Am Acad Dermatol (2008) 0.78
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. Appl Immunohistochem Mol Morphol (2010) 0.78
MtmMII-mediated C-methylation during biosynthesis of the antitumor drug mithramycin is essential for biological activity and DNA-drug interaction. J Biol Chem (2003) 0.78
Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor. Australas J Dermatol (2011) 0.77
Surface glycosaminoglycans mediate adherence between HeLa cells and Lactobacillus salivarius Lv72. BMC Microbiol (2013) 0.77
The number and growth pattern of plasmacytoid dendritic cells vary in different types of reactive lymph nodes: an immunohistochemical study. Hum Pathol (2012) 0.76
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas. Haematologica (2010) 0.76
Lack of association between angiotensin I-converting enzyme insertion/deletion polymorphism and psoriasis or psoriatic arthritis in Spain. Int J Dermatol (2009) 0.76
New psoriasis susceptibility genes: momentum for skin-barrier disruption. J Invest Dermatol (2011) 0.76
Fatal outcome due to bacterial superinfection of eczema herpeticum in a patient with mycosis fungoides. Dermatol Online J (2008) 0.76
Hepatic adenomatosis: a rare cause of liver transplant. Rev Esp Enferm Dig (2014) 0.76
Apolipoprotein epsilon4 allele is associated with psoriasis severity: reply. Arch Dermatol Res (2010) 0.76
Multiple eruptive dermatofibromas in a patient receiving efalizumab. Dermatology (2008) 0.75
Death from cerebrovascular infarction in a patient with PHACES syndrome. J Am Acad Dermatol (2004) 0.75
Common European mitochondrial haplogroups in the risk for psoriasis and psoriatic arthritis. Genet Test Mol Biomarkers (2011) 0.75
64 Year-Old Woman with Longstanding Migraine. Primary Diffuse Leptomeningeal Gliomatosis (PDLG) (WHO Grade III). Brain Pathol (2015) 0.75
Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach. Haematologica (2002) 0.75
SNP rs11652075 in the CARD14 gene as a risk factor for psoriasis (PSORS2) in a Spanish cohort. DNA Cell Biol (2013) 0.75
Efficacy of adalimumab in the treatment of moderate-to-severe psoriasis: A retrospective study of 100 patients in daily practice. J Dermatolog Treat (2014) 0.75
Multiple lentigines confined to resolving psoriatic plaques in a patient treated with adalimumab. Dermatology (2008) 0.75
The expression of Bcl-2 by proliferating cells varies in different categories of B-cell lymphoma. Histopathology (2010) 0.75
Diagnostic Pitfalls in "Low-Grade Lymphoma" of the Orbit and Lacrimal Gland. Orbit (2015) 0.75
Circumscribed palmar hypokeratosis. J Am Acad Dermatol (2009) 0.75
Lichen striatus in an adult following trauma with central nail plate involvement and its dermoscopy features. Int J Dermatol (2008) 0.75
The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients. Pharmacogenet Genomics (2015) 0.75
Cutaneous Rosai-Dorfman disease following a classical Hodgkin lymphoma, nodular sclerosis subtype. Am J Dermatopathol (2014) 0.75
Heterogeneous expression of B cell-associated markers in follicular lymphoma. Histopathology (2011) 0.75
Christian Schad and Dr Haustein: an example of art and dermatology under the Nazi regime. Arch Dermatol (2008) 0.75